Abstract
Background Cerebellar intracerebral hemorrhage (cICH) is often attributed to hypertension or cerebral amyloid angiopathy (CAA). However, deciphering the exact etiology can be challenging. A recent study reported a topographic etiologic relationship with superficial cICH secondary to CAA. We aimed to re-examine this relationship between topography and etiology in a separate cohort of patients and using the most recent Boston criteria version 2.0.
Methods Retrospective analysis of consecutive patients with primary cICH admitted to a tertiary academic center between 2000-2022. cICH location on brain CT/MRI scan(s) was divided into strictly superficial (cortex, surrounding white matter, vermis), vs deep (cerebellar nuclei, deep white matter) or mixed (both regions). MRIs were rated for markers of cerebral small vessel disease. We assigned possible/probable vs absent CAA using Boston criteria 2.0.
Results We included 197 patients; 106 (53.8%) females, median age 74 (63-82) years. Fifty-six (28%) patients had superficial cICH and 141 (72%) deep/mixed cICH. MRI was available for 112 (57%) patients [30(26.8%) with superficial and 82(73.2%) with deep/mixed cICH]. Superficial cICH patients were more likely to have possible/probable CAA (48.3% vs 8.6%; OR 11.43, 95%CI 3.26-40.05; p<0.001), strictly lobar cerebral microbleeds (CMBs) (51.7% vs 6.2%; OR 14.18, 95%CI 3.98-50.50; p<0.001), and cortical superficial siderosis (13.8% vs 1.2%; OR 7.70, 95%CI 0.73-80.49; p=0.08). Patients with deep/mixed cICH patients were more likely to have deep/mixed CMBs (59.2% vs 3.4%; OR 41.39, 95% CI 5.01-341.68; p=0.001), lacunes (54.9% vs 17.2%; OR 6.14, 95% CI 1.89-19.91; p=0.002), severe basal ganglia enlarged perivascular spaces (36.6% vs 7.1%; OR 7.63, 95% CI 1.58-36.73; p=0.01), hypertension (84.4% vs 62.5%; OR 3.43, 95% CI 1.61,-7.30; p=0.001), and higher admission systolic blood pressure (172 [146-200] vs 146 [124-158] mmHg, p<0.001).
Conclusions Our results suggest that superficial cICH is strongly associated with CAA whereas deep/mixed cICH is almost exclusively linked to hypertensive arteriopathy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Drs. Lioutas and Selim receive grant funding from the NIH (U01NS102289, UF1NS120871, R01NS01795).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Beth Israel Deaconess Medical Center IRB.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
The data will be available upon reasonable request.
